Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Becton Dickinson's $12B CareFusion Buyout Set to Close Tomorrow

Tuesday, March 17, 2015   (0 Comments)
Share |
From MassDevice
By Brad Perriello

Becton Dickinson's $12 billion acquisition of CareFusion is set to close tomorrow, after European anti-trust regulators approved the merger last week.

The $12.2 billion merger of Becton Dickinson (NYSE:BDX) and CareFusion (NYSE:CFN) is slated to close tomorrow, the companies said, after European anti-trust regulators last week approved the deal.

Franklin Lakes, N.J.-based Becton agreed last October to pay a total of $58.00 a share – $49.00 in cash and 0.0777 of a BDX share – for each CFN share, representing a premium of 26% to the closing price on Oct. 3.

The deal would unite 2 complementary product lines: BD makes products to deliver and administer drugs, such as disposable needles, syringes and intravenous catheters, while CareFusion makes products to store and deliver drugs, such as infusion pumps.

Anti-trust regulators in the U.S. approved the deal last November; the EU nod was the buyout's final regulatory hurdle, according to a regulatory filing, setting the stage for a closing tomorrow.

[Read rest of article online]

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal